<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">35051135</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1545-861X</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>21</Day></PubDate></JournalIssue><Title>MMWR. Morbidity and mortality weekly report</Title><ISOAbbreviation>MMWR Morb Mortal Wkly Rep</ISOAbbreviation></Journal><ArticleTitle>Progress Toward Poliomyelitis Eradication - Afghanistan, January 2020-November 2021.</ArticleTitle><Pagination><StartPage>85</StartPage><EndPage>89</EndPage><MedlinePgn>85-89</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.15585/mmwr.mm7103a3</ELocationID><Abstract><AbstractText>Wild poliovirus types 2 and 3 were declared eradicated in 2015 and 2019, respectively, and, since 2017, transmission of wild poliovirus type 1 (WPV1) has been detected only in Afghanistan and Pakistan. In 2020, these countries reported their highest number of WPV1 cases since 2014 and experienced outbreaks of type 2 circulating vaccine-derived poliovirus (cVDPV2)* (1); in Afghanistan, the number of WPV1 cases reported increased 93%, from 29 in 2019 to 56 in 2020, with 308 cVDPV2 cases reported. This report describes the activities and progress toward polio eradication in Afghanistan during January 2020-November 2021 and updates previous reports (2-4). Despite restrictions imposed by antigovernment elements since 2018, disruption of polio eradication efforts by the COVID-19 pandemic, and civil and political instability, eradication activities have resumed. During January-November 2021, four WPV1 cases and 43 cVDPV2 cases were detected, representing decreases of 93% from 56 and 85% from 281, respectively, during the same period in 2020. After the assumption of nationwide control by the current de facto government of Afghanistan during August 2021, health officials committed to oral poliovirus vaccine (OPV) campaigns nationwide, with the potential to vaccinate approximately 2.5 million children against poliovirus who were previously not accessible for &#x2265;2 years. Although challenges remain, vigorous, sustained polio eradication efforts in Afghanistan could result in substantial progress toward eradication during 2022-2023.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sadigh</LastName><ForeName>Katrin S</ForeName><Initials>KS</Initials></Author><Author ValidYN="Y"><LastName>Akbar</LastName><ForeName>Irfan Elahi</ForeName><Initials>IE</Initials></Author><Author ValidYN="Y"><LastName>Wadood</LastName><ForeName>Mufti Zubair</ForeName><Initials>MZ</Initials></Author><Author ValidYN="Y"><LastName>Shukla</LastName><ForeName>Hemant</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Jorba</LastName><ForeName>Jaume</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Chaudhury</LastName><ForeName>Sumangala</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Martinez</LastName><ForeName>Maureen</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016427">Technical Report</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>MMWR Morb Mortal Wkly Rep</MedlineTA><NlmUniqueID>7802429</NlmUniqueID><ISSNLinking>0149-2195</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000346" MajorTopicYN="N" Type="Geographic">Afghanistan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060740" MajorTopicYN="Y">Disease Eradication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="Y">Immunization Programs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="N">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="Y">Population Surveillance</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>20</Day><Hour>17</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35051135</ArticleId><ArticleId IdType="pmc">PMC8774155</ArticleId><ArticleId IdType="doi">10.15585/mmwr.mm7103a3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chard AN, Datta SD, Tallis G, et al. Progress toward polio eradication&#x2014;worldwide, January 2018&#x2013;March 2020. MMWR Morb Mortal Wkly Rep 2020;69:784&#x2013;9. 10.15585/mmwr.mm6925a4</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6925a4</ArticleId><ArticleId IdType="pmc">PMC7316320</ArticleId><ArticleId IdType="pubmed">32584798</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez M, Akbar IE, Wadood MZ, Shukla H, Jorba J, Ehrhardt D. Progress toward poliomyelitis eradication&#x2014;Afghanistan, January 2019&#x2013;July 2020. MMWR Morb Mortal Wkly Rep 2020;69:1464&#x2013;8. 10.15585/mmwr.mm6632a5</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6632a5</ArticleId><ArticleId IdType="pmc">PMC7561224</ArticleId><ArticleId IdType="pubmed">33031360</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez M, Shukla H, Nikulin J, Mbaeyi C, Jorba J, Ehrhardt D. Progress toward poliomyelitis eradication&#x2014;Afghanistan, January 2018&#x2013;May 2019. MMWR Morb Mortal Wkly Rep 2019;68:729&#x2013;33. 10.15585/mmwr.mm6632a5</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6632a5</ArticleId><ArticleId IdType="pmc">PMC6705892</ArticleId><ArticleId IdType="pubmed">31437144</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez M, Shukla H, Nikulin J, et al. Progress toward poliomyelitis eradication&#x2014;Afghanistan, January 2016&#x2013;June 2017. MMWR Morb Mortal Wkly Rep 2017;66:854&#x2013;8. 10.15585/mmwr.mm6632a5</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6632a5</ArticleId><ArticleId IdType="pmc">PMC5657670</ArticleId><ArticleId IdType="pubmed">28817551</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2020 global summary. Geneva, Switzerland: World Health Organization; 2020. https://apps.who.int/immunization_monitoring/globalsummary/countries?countrycriteria%5Bcountry%5D%5B%5D=AFG</Citation></Reference><Reference><Citation>Alleman MM, Jorba J, Henderson E, et al. Update on vaccine-derived poliovirus outbreaks&#x2014;worldwide, January 2020&#x2013;June 2021. MMWR Morb Mortal Wkly Rep 2021;70:1691&#x2013;9. 10.15585/mmwr.mm7049a1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7049a1</ArticleId><ArticleId IdType="pmc">PMC8659190</ArticleId><ArticleId IdType="pubmed">34882653</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CH, Rehman MS, Bullard K, et al. Progress toward poliomyelitis eradication&#x2014;Pakistan, January 2019&#x2013;September 2020. MMWR Morb Mortal Wkly Rep 2020;69:1748&#x2013;52. 10.15585/mmwr.mm6946a5</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6946a5</ArticleId><ArticleId IdType="pmc">PMC7676637</ArticleId><ArticleId IdType="pubmed">33211676</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>